Cardiovascular, Pulmonary and Skeletal Muscle Evaluation in Late Postoperative Period of the Fontan Surgery

Sponsor
University of Sao Paulo (Other)
Overall Status
Unknown status
CT.gov ID
NCT02283255
Collaborator
InCor Heart Institute (Other), Fundação de Amparo à Pesquisa do Estado de São Paulo (Other)
60
1
4
48
1.3

Study Details

Study Description

Brief Summary

Introduction: Different variations of the Fontan operation has been used to treat complex cardiac anomalies with a single functional ventricle. This procedure has substantially improved quality of life and survival in patients with these complex cardiac anomalies. However, the cardiovascular and pulmonary functioning as well as skeletal muscle alterations that can explain the exercise intolerance in these patients is still poorly understood.

Objectives: 1) To evaluate effects of different exercise programs on adolescents and adults with Fontan circulation.

Methods: A long-term randomized clinical study that will include 60 patients between 12 and 30 years, submitted to total cavopulmonary connection for at least 5 years post operative at the Heart Institute, University of São Paulo Medical School. The patients will be divided into four groups: 1) Exercise training with aerobic exercise + lower and upper limb strength exercise (GTF-I); 2) Respiratory training with respiratory muscle exercise (GTF-II); 3) Exercise training with aerobic exercise + lower and upper limb strength exercise + Respiratory training with respiratory muscle exercise (GTF-III); and A non-exercise group as control group (GNTF-IV). The patients will be revaluated after the 4-month period of intervention.

Expected Outcomes: The investigators expect to demonstrate that exercise training and respiratory training can substantially improve the cardiovascular and pulmonary responses and skeletal muscle system in patients with univentricular circulation. In addition, the investigators wil test the hypothesis that the effects of exercise training associated with respiratory training on cardiovascular and pulmonary responses and skeletal muscle system may be greater than exercise training or respiratory training alone.

Condition or Disease Intervention/Treatment Phase
  • Other: Physical Activity
N/A

Detailed Description

This research proposes to evaluate patients after undergoing the Fontan surgery. The investigators want to understanding exercise intolerance and they want to demonstrate the effects of exercise training after different programs of physical exercise. As well as, the quality of life.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Cardiovascular, Pulmonary and Skeletal Muscle Evaluation in Patients With Univentricular Physiology in the Late Postoperative Period of the Fontan Surgery: Effects of Exercise Training
Study Start Date :
Jan 1, 2013
Anticipated Primary Completion Date :
Jan 1, 2016
Anticipated Study Completion Date :
Jan 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Physical Activity 1

Aerobic Training: Aerobic training and muscle strength exercise for upper and lower limbs, 3 times a week for 4 months.

Other: Physical Activity
Physical Activity, Exercise training: aerobic and respiratory exercise with POWERbreathe device
Other Names:
  • Exercise training: aerobic and respiratory exercise
  • Active Comparator: Physical Activity 2

    Respiratory Training: muscle training using POWERbreathe device, 7 times a week, 3 series of 30 repetitions per day, for 4 months.

    Other: Physical Activity
    Physical Activity, Exercise training: aerobic and respiratory exercise with POWERbreathe device
    Other Names:
  • Exercise training: aerobic and respiratory exercise
  • Active Comparator: Physical Activity 3

    Aerobic and Respiratory Training: Aerobic training and muscle strength exercise for upper and lower limbs, 3 times a week for 4 months and respiratory muscle training using POWERbreathe device, 7 times a week, 3 series of 30 repetitions per day, for 4 months.

    Other: Physical Activity
    Physical Activity, Exercise training: aerobic and respiratory exercise with POWERbreathe device
    Other Names:
  • Exercise training: aerobic and respiratory exercise
  • No Intervention: Physical Activity 4

    No Physical Activity: Control group (usual care)

    Outcome Measures

    Primary Outcome Measures

    1. Improvement exercise tolerance and physical capacity [Baseline and 4 months]

      Change in parameters by cardiopulmonary exercise test; increase in lung volumes and capacities; improvement by neurovascular control and skeletical muscle metabolism

    Other Outcome Measures

    1. Improvement in the functional capacity post exercise training program [baseline and 4 months]

      Increase at least 20% cardiopulmonary exercise test parameters: VO2 peak, oxygen pulse and VE/VCO2 slope

    2. Improvement in pulmonary function post physical exercise program [baseline and 4 months]

      Achieve at least 80% of predicted values for age at pulmonary function testing: spirometry, plethysmography, carbon monoxide diffusion capacity and maximal inspiratory pressure

    3. Change in autonomic function post exercise training program [baseline and 4 months]

      Decrease bursts/min and bursts per 100 heart beats by at least 20% from baseline by directly measured by microneurography : direct muscle sympathetic nerve activity (MSNA)

    4. Improvement in peripheral blood flow post exercise training program [baseline and 4 months]

      Increase forearm blood flow in mL/min/100mL

    5. Change in the plasma epinephrine level post exercise training program [baseline and 4 months]

      Decrease of plasma epinephrine level from baseline

    6. Change in muscle metabolism post exercise training program [baseline and 4 months]

      Increase of the amplitudes of the phosphocreatine, inorganic phosphate and ATP from baseline by 31P-MRS: Quadriceps femoral 31P-MRS

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    12 Years to 30 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Both gender, aged between 12 and 30 years

    • Patients undergoing the Fontan operation with time postoperatively ≥5 years

    • Clinically stable patients, no arrhythmia in the last electrocardiogram or clinical assessment

    • Consent by the cardiologist

    • Patients who voluntarily signed the consent form.

    Exclusion Criteria:
    • Patients with hypoplastic left heart syndrome

    • Changes that reduce musculoskeletal walking skills

    • Neurological sequelae, patients with associated genetic syndrome, disturbance cognitive or psychiatric

    • Patients with a history of ventricular arrhythmias, cardio respiratory arrest, users of anti-arrhythmic drugs and / or underwent implantation of pacemaker

    • Atrial arrhythmia requiring treatment in the last 6 months

    • Patients with heart failure not controlled by medications and lung hypertension

    • Patients with protein-losing enteropathy

    • Severe hypoxemia (oxygen saturation <80% at rest)

    • Symptomatic patients with a diagnosis of diaphragmatic paresis or paralysis postoperative patients, with or without plication

    • Patients with moderate to severe asthma

    • Patients who live outside the area of Sao Paulo

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 InCor Heart Institute Sao Paulo Brazil 05403000

    Sponsors and Collaborators

    • University of Sao Paulo
    • InCor Heart Institute
    • Fundação de Amparo à Pesquisa do Estado de São Paulo

    Investigators

    • Study Chair: Marcelo B Jatene, MD,PhD, Heart Institute, University of Sao Paulo, Medical School
    • Principal Investigator: Aida LR Turquetto, PhD student, Heart Institute, University of Sao Paulo, Medical School

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Aida Luiza R Turquetto, InCor Heart Institute, University of Sao Paulo
    ClinicalTrials.gov Identifier:
    NCT02283255
    Other Study ID Numbers:
    • CAPPesq 3765/12/021
    First Posted:
    Nov 5, 2014
    Last Update Posted:
    Nov 5, 2014
    Last Verified:
    Oct 1, 2014
    Keywords provided by Aida Luiza R Turquetto, InCor Heart Institute, University of Sao Paulo
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 5, 2014